EE254 The Cost-Consequence of Budesonide/Formoterol Plus As-Needed Saba As Treatment for 6-12 Years Old Pediatric Asthma Patients in ChinaBased on Real-World Data

Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.553
https://www.valueinhealthjournal.com/article/S1098-3015(24)00668-5/fulltext
Title : EE254 The Cost-Consequence of Budesonide/Formoterol Plus As-Needed Saba As Treatment for 6-12 Years Old Pediatric Asthma Patients in ChinaBased on Real-World Data
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00668-5&doi=10.1016/j.jval.2024.03.553
First page :
Section Title :
Open access? : No
Section Order : 10028
Categories :
Tags :
Regions :
ViH Article Tags :